All Projects
Showing 1-10 of 1583 projects
CANnabidiol for Parkinson’s Disease Psychosis | C4C
- Applicant: Sagnik Bhattacharyya
- Project ID: 21-058
Retrospective study of anti-depressants as potential prophylactics against COVID-19
- Applicant: Christoph Mueller
- Project ID: 21-059
Associations of QT prolonging medications with adverse outcomes
- Applicant: Vidya Giri Shankar
- Project ID: 21-060
Associations of medications known to cause hyponatremia with adverse outcomes
- Applicant: Vidya Giri Shankar
- Project ID: 21-061
Exploring occupational information and interventions in CRIS
- Applicant: Sarah Dorrington
- Project ID: 21-062
Evaluating remote delivery of Cognitive Remediation in people with psychosis | C4C
- Applicant: Lauren Harrison
- Project ID: 21-063
A randomised, placebo-controlled, singleblind study to characterise the biomarker effects of the CSF-1 receptor antagonist JNJ- 40346527 in participants with mild cognitive impairment | C4C
- Applicant: Zunera Khan
- Project ID: 21-064
TESTING A TECHNOLOGY SUPPORTED AND SOLUTION-FOCUSED INTERVENTION (DIALOG+) FOR PEOPLE WITH CHRONIC DEPRESSION | C4C
- Applicant: Zunera Khan
- Project ID: 21-065
COVID-19 Clinical Neuroscience Study (COVID-CNS) | C4C
- Applicant: Gabriella Lewis
- Project ID: 21-066
Examining differences in socio-demographic and clinical characteristics in young people treated by Child and Adolescent ADHD services by age of first diagnosis
- Applicant: Ana Maria Butura
- Project ID: 21-067
